El-sigarett
943true dots bottomright 319true true 800http://www.niprd.net/wp-content/plugins/thethe-image-slider/style/skins/white-rounded
  • 5000 random true 60 bottom 30
    Slide1
    NIPRD Head Office
  • 5000 random true 60 bottom 30
    Slide9
    Director General/Chief Executive, Professor K. S. Gamaniel, OON, FAS, FPSN, FPCPharm.
  • 5000 random true 60 bottom 30
    Slide5
    Innovation Award
  • 5000 random true 60 bottom 30
    Slide8
    Our scientists on the bench conducting R&D
  • 5000 random true 60 bottom 30
    Slide8
    Prof. Isaac Adewole, Honourable Minister of Health and Prof. Karniyus Gamaniel, DG NIPRD
  • 5000 random true 60 bottom 30
    Slide11
    Senate Committee on Health pays Oversight Function visit to NIPRD
  • 5000 random true 60 bottom 30
    Slide7
    The DG, NIPRD on PSN delegation on a courtesy visit to President Muhammadu Buhari, GCFR
  • 5000 random true 60 bottom 30
    Slide8
    The President, PSN (Pharm) Ahmed Yakassai visits NIPRD
  • 5000 random true 60 bottom 30
    Slide9
    PSN (Abuja Chapter) new EXCO pays a familiarization/courtesy visit to NIPRD

Research Projects

Projects undertaken by the institute:

  • Formation of contraceptive preparation obtained from natural products.

    Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.
  • Development of pharmaceutical grade starch from local sources and preparation of feasibility report on same.

    Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.
  • Production of microcrystalline cellulose from elephant grass and corn stalk.

    Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.
  • Assessment of semi-processed kaolin for production of pharmaceutical grade kaolin.

    Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.
  • Assessment of locally available colorant as a pharmaceutical expicient.

    Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.
  • Development of analytical “fingerprints” for some herbal medicines.

    Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.
  • Provision of clinical services to the public.

    Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.
  • Provision of ARVs through the federal government ARV programme.

    Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.
  • Validation of claims by TMPs on effectiveness of some herbal medicines against HIV/AIDS, malaria, tuberculosis etc.

    Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.
  • Screening of medicinal plants for activity against tuberculosis and HIV/AIDS.

    Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.
  • National CD4 baseline counts study.

    Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.
  • Development of phytomedicine for the management of sickle cell disease.

    Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.
  • Development of anti-malaria phytomedicine .

    Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.
  • Development of an immune booster, a phytomedicine for the management of persons with HIV/AIDS.

    Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.Lorem Ipsum Is Dummy Text.

picture